Cargando…
Innovation Experiences from Africa-Led Drug Discovery at the Holistic Drug Discovery and Development (H3D) Centre
[Image: see text] As the so-called “next frontier” in global economic terms, Africa’s disease burden continues to choke and cripple economic growth across the continent. The highest burden is attributable to malaria and tuberculosis (TB), which also remain among the deadliest infectious diseases aff...
Autores principales: | Singh, Vinayak, Mambwe, Dickson, Korkor, Constance Mawunyo, Chibale, Kelly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9377003/ https://www.ncbi.nlm.nih.gov/pubmed/35978699 http://dx.doi.org/10.1021/acsmedchemlett.2c00142 |
Ejemplares similares
-
First fully-automated AI/ML virtual screening cascade implemented at a drug discovery centre in Africa
por: Turon, Gemma, et al.
Publicado: (2023) -
Correction: Recent updates in the discovery and development of novel antimalarial drug candidates
por: Okombo, John, et al.
Publicado: (2018) -
Insights into Integrated Lead Generation and Target
Identification in Malaria and Tuberculosis Drug Discovery
por: Okombo, John, et al.
Publicado: (2017) -
Antimalarial drug discovery: progress and approaches
por: Siqueira-Neto, Jair L, et al.
Publicado: (2023) -
Strategies to Combat Multi-Drug Resistance in Tuberculosis
por: Singh, Vinayak, et al.
Publicado: (2021)